$0.336
0.021[6.67%]
Last update: 9:18AM Get Real Time Here
Qualigen Therapeutics
(NASDAQ:QLGN)Qualigen Therapeutics Stock (NASDAQ:QLGN), Earnings Estimates, EPS, and Revenue
Qualigen Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-0.520
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Qualigen Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/14/2024 | AM | QLGN | Q1 | -$0.78 | — | — | — | $1.61M | — | — | — | Get Alert |
| 05/07/2024 | PM | QLGN | Q4 | -$1.55 | -$0.52 | — | — | $1.39M | — | — | — | Get Alert |
| 11/14/2023 | AM | QLGN | Q3 | -$1.00 | -$0.92 | -$0.64 | 30.43% | $1.44M | $500.00K | $0.00 | -100.00% | Get Alert |
| 08/15/2023 | AM | QLGN | Q2 | -$1.10 | -$0.52 | -$0.69 | -32.69% | $1.43M | $1.60M | $1.63M | 1.69% | Get Alert |
| 05/16/2023 | AM | QLGN | Q1 | -$1.20 | — | -$0.78 | — | $722.03K | $2.00M | $1.61M | -19.64% | Get Alert |
| 05/02/2023 | PM | QLGN | Q4 | -$2.00 | — | -$1.55 | — | $1.48M | — | $1.39M | — | Get Alert |
| 11/15/2022 | AM | QLGN | Q3 | -$1.00 | -$1.30 | -$1.00 | 23.08% | $1.16M | $1.62M | $1.44M | -11.05% | Get Alert |
| 08/16/2022 | AM | QLGN | Q2 | -$1.80 | — | -$1.10 | — | $1.12M | — | $1.43M | — | Get Alert |
| 05/13/2022 | AM | QLGN | Q1 | -$1.30 | — | -$1.20 | — | $1.90M | — | $722.03K | — | Get Alert |
| 03/31/2022 | PM | QLGN | Q4 | -$31.70 | -$1.70 | -$2.00 | -17.65% | $2.71M | $1.75M | $1.48M | -15.37% | Get Alert |
| 11/15/2021 | AM | QLGN | Q3 | $4.10 | -$1.90 | -$1.00 | 47.37% | $1.11M | $1.70M | $1.16M | -32.06% | Get Alert |
| 08/17/2021 | AM | QLGN | Q2 | -$4.10 | -$1.80 | -$1.80 | 0.00% | $837.71K | $1.60M | $1.12M | -30.13% | Get Alert |
| 05/14/2021 | PM | QLGN | Q1 | -$21.20 | — | -$1.30 | — | $904.07K | — | $1.90M | — | Get Alert |
| 03/31/2021 | AM | QLGN | Q3 | — | -$1.30 | $4.10 | 415.38% | — | $2.00M | $1.11M | -44.60% | Get Alert |
| 03/31/2021 | AM | QLGN | Q4 | — | — | -$31.70 | — | — | — | $2.71M | — | Get Alert |
| 11/12/2020 | PM | QLGN | Q2 | — | — | -$4.10 | — | — | — | $837.71K | — | Get Alert |
| 08/14/2020 | PM | QLGN | Q1 | — | — | -$21.20 | — | — | — | $904.07K | — | Get Alert |
FAQ
When is Qualigen Therapeutics (NASDAQ:QLGN) reporting earnings?
Qualigen Therapeutics (QLGN) is scheduled to report earnings on May 14, 2024. The last reported earnings were for reported on November 14, 2023 for Q3.
What were the latest earnings per share (EPS) for Qualigen Therapeutics (NASDAQ:QLGN)?
The Actual EPS was $-0.64, which beat the estimate of $-0.92.
What were Qualigen Therapeutics’s (NASDAQ:QLGN) revenues?
The Actual Revenue was $0K, which missed the estimate of $500K.
Browse earnings estimates, EPS, and revenue on all stocks.